Deyaa Adib - Net Worth and Insider Trading
Deyaa Adib Net Worth
The estimated net worth of Deyaa Adib is at least $26,214 dollars as of 2026-09-11. Deyaa Adib is the Chief Medical Officer of Kyntra Bio Inc and owns about 3,285 shares of Kyntra Bio Inc (KYNB) stock worth over $26,214. Details can be seen in Deyaa Adib's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deyaa Adib has not made any transactions after 2024-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deyaa Adib
Deyaa Adib Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deyaa Adib owns 1 companies in total, including Kyntra Bio Inc (KYNB) .
Click here to see the complete history of Deyaa Adib’s form 4 insider trades.
Insider Ownership Summary of Deyaa Adib
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| KYNB | Kyntra Bio Inc | 2024-04-22 | Chief Medical Officer |
Deyaa Adib Latest Holdings Summary
Deyaa Adib currently owns a total of 1 stock. Deyaa Adib owns 3,285 shares of Kyntra Bio Inc (KYNB) as of June 12, 2024, with a value of $26,214.
Latest Holdings of Deyaa Adib
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KYNB | Kyntra Bio Inc | 2024-06-12 | 3,285 | 7.98 | 26,214 |
Holding Weightings of Deyaa Adib
Deyaa Adib Form 4 Trading Tracker
According to the SEC Form 4 filings, Deyaa Adib has made a total of 1 transactions in Kyntra Bio Inc (KYNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kyntra Bio Inc is the acquisition of 885 shares on June 12, 2024, which cost Deyaa Adib around $25,884.
Insider Trading History of Deyaa Adib
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Deyaa Adib Trading Performance
GuruFocus tracks the stock performance after each of Deyaa Adib's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deyaa Adib is -63.51%. GuruFocus also compares Deyaa Adib's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deyaa Adib within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deyaa Adib's insider trading performs compared to the benchmark.
Performance of Deyaa Adib
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.34 | | | | | |
| Relative Return to S&P 500(%) | -13.92 | | | | | |
Deyaa Adib Ownership Network
Ownership Network List of Deyaa Adib
Ownership Network Relation of Deyaa Adib
Deyaa Adib Owned Company Details
What does Kyntra Bio Inc do?
Who are the key executives at Kyntra Bio Inc?
Deyaa Adib is the Chief Medical Officer of Kyntra Bio Inc. Other key executives at Kyntra Bio Inc include Chief Commercial Officer Thane Wettig , Chief Financial Officer David Delucia , and director & Chief Executive Officer Enrique A Conterno .
Kyntra Bio Inc (KYNB) Insider Trades Summary
Over the past 18 months, Deyaa Adib made no insider transaction in Kyntra Bio Inc (KYNB). Other recent insider transactions involving Kyntra Bio Inc (KYNB) include a net purchase of 323,567 shares made by James A Schoeneck , and a net purchase of 148,700 shares made by Thane Wettig .
In summary, during the past 3 months, insiders sold 0 shares of Kyntra Bio Inc (KYNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kyntra Bio Inc (KYNB) were sold and 45,067 shares were bought by its insiders, resulting in a net purchase of 45,067 shares.
Kyntra Bio Inc (KYNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kyntra Bio Inc Insider Transactions
Deyaa Adib Mailing Address
Above is the net worth, insider trading, and ownership report for Deyaa Adib. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Deyaa Adib's mailing address is: San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
